BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24773382)

  • 1. An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients.
    Lieberman L; Liu Y; Portwine C; Barty RL; Heddle NM
    Transfusion; 2014 Oct; 54(10 Pt 2):2736-44. PubMed ID: 24773382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
    Butler CE; Noel S; Hibbs SP; Miles D; Staves J; Mohaghegh P; Altmann P; Curnow E; Murphy MF
    Transfusion; 2015 Aug; 55(8):1964-71. PubMed ID: 25906831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients.
    Shaz BH; Dente CJ; Nicholas J; MacLeod JB; Young AN; Easley K; Ling Q; Harris RS; Hillyer CD
    Transfusion; 2010 Feb; 50(2):493-500. PubMed ID: 19804568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet utilization and the transfusion trigger: a prospective analysis.
    Greeno E; McCullough J; Weisdorf D
    Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a pediatric trauma massive transfusion protocol: one institution's experience.
    Hendrickson JE; Shaz BH; Pereira G; Parker PM; Jessup P; Atwell F; Polstra B; Atkins E; Johnson KK; Bao G; Easley KA; Josephson CD
    Transfusion; 2012 Jun; 52(6):1228-36. PubMed ID: 22128884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).
    Warner MA; Jambhekar NS; Saadeh S; Jacob EK; Kreuter JD; Mundell WC; Marquez A; Higgins AA; Madde NR; Hogan WJ; Kor DJ
    Transfusion; 2019 Sep; 59(9):2840-2848. PubMed ID: 31222775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in red blood cell transfusion practice during the past quarter century: a retrospective analysis of pediatric patients undergoing elective scoliosis surgery using the Mayo database.
    Long TR; Stans AA; Shaughnessy WJ; Joyner MJ; Schroeder DR; Wass CT
    Spine J; 2012 Jun; 12(6):455-62. PubMed ID: 22561177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of red blood cell and platelet allo-antibodies in platelet alloimmunized patients].
    Moncharmont P; Rigal D
    Transfus Clin Biol; 2014 Jun; 21(3):99-102. PubMed ID: 24948207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion treatment at Sestre Milosrdnice University Hospital Center during a twelve-year period.
    Sović D; Dodig J; Banović M; Jularić A
    Acta Clin Croat; 2014 Sep; 53(3):342-7. PubMed ID: 25509245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital.
    Vonk AB; Meesters MI; van Dijk WB; Eijsman L; Romijn JW; Jansen EK; Loer SA; Boer C
    Transfusion; 2014 Oct; 54(10 Pt 2):2608-16. PubMed ID: 24372139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Utilization and Transfusion Reactions in Pediatric Patients Transfused with Conventional or Pathogen Reduced Platelets.
    Schulz WL; McPadden J; Gehrie EA; Bahar B; Gokhale A; Ross R; Price N; Spencer BR; Snyder E
    J Pediatr; 2019 Jun; 209():220-225. PubMed ID: 30885645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
    Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O
    Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists.
    Wong EC; Perez-Albuerne E; Moscow JA; Luban NL
    Pediatr Blood Cancer; 2005 Feb; 44(2):119-27. PubMed ID: 15452914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell transfusion practice in children: current status and areas for improvement? A study of the use of red blood cell transfusions in children and infants.
    New HV; Grant-Casey J; Lowe D; Kelleher A; Hennem S; Stanworth SJ
    Transfusion; 2014 Jan; 54(1):119-27. PubMed ID: 23808415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
    Goel R; Nellis ME; Karam O; Hanson SJ; Tormey CA; Patel RM; Birch R; Sachais BS; Sola-Visner MC; Hauser RG; Luban NLC; Gottschall J; Josephson CD; Hendrickson JE; Karafin MS;
    Transfusion; 2021 Sep; 61(9):2589-2600. PubMed ID: 34455598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggers and appropriateness of red blood cell transfusions in the postpartum patient--a retrospective audit.
    So-Osman C; Cicilia J; Brand A; Schipperus M; Berning B; Scherjon S
    Vox Sang; 2010 Jan; 98(1):65-9. PubMed ID: 19686225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective computerized order auditing.
    Yerrabothala S; Desrosiers KP; Szczepiorkowski ZM; Dunbar NM
    Transfusion; 2014 Oct; 54(10 Pt 2):2640-5. PubMed ID: 24673396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness.
    Edwards J; Morrison C; Mohiuddin M; Tchatalbachev V; Patel C; Schwickerath VL; Menitove JE; Singh G
    Transfusion; 2012 Nov; 52(11):2445-51. PubMed ID: 22413968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.